We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Frucht, S, Rogers, JD, Greene, PE, et al.Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology.1999; 52:1908–20.CrossRefGoogle ScholarPubMed
2
2.Moller, H.Antiparkinsonian drugs and “sleep attacks”. Canadian Adverse Drug Reaction Newsletter. 2001; 11:3–4.Google Scholar
3
3.Hobson, DE, Lang, AE, Martin, WRW, Razmy, A, Rivest, J, Fleming, J.Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA.2002; 287:455–63.Google Scholar
4
4.Schapira, AH.Excessive daytime sleepiness in Parkinson’s disease. Neurology.2004; 63:S24–7Google Scholar
5
5.Möller, JC, Körner, Y, Cassel, W, et al.Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome. Sleep Med.2006; 7:333–9.Google Scholar
6
6.Ondo, WG, Vuong, KD, Khan, H, Atassi, F, Kwak, C, Jankovic, J.Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology.2001; 57:1392–6.Google Scholar
7
7.de Bie, RMA, Miyasaki, J, Lang, AE, Fox, SH.Clinical practice regarding dopamine-agonist use and driving in Parkinson’s disease. Can J Neurol Sci.2007; 34:438–42.Google Scholar